在阿替沙班相关肝素抵抗中成功应用抗凝血酶 - Suppr

Successful Antithrombin Administration in Andexanet Alfa-Associated Heparin Resistance.

作者信息

Apostel Heleen J C L, Winckers Kristien, Bidar Elham, Schreiber Jan-Uwe

机构信息

Departement of Anesthesiology and Pain Management, Maastricht Universitair Medisch Centrum, Maastricht, The Netherlands.

Departement of Internal Medicine, Maastricht Universitair Medisch Centrum, Maastricht, The Netherlands.

出版信息

J Cardiothorac Vasc Anesth. 2021 Mar;35(3):904-907. doi: 10.1053/j.jvca.2020.10.042. Epub 2020 Oct 24.

DOI:10.1053/j.jvca.2020.10.042

PMID:33187852

Abstract

摘要

相似文献

Successful Antithrombin Administration in Andexanet Alfa-Associated Heparin Resistance.

J Cardiothorac Vasc Anesth. 2021 Mar;35(3):904-907. doi: 10.1053/j.jvca.2020.10.042. Epub 2020 Oct 24.

Antithrombin supplementation attenuates heparin resistance in plasma spiked with Gla-domainless factor Xa S195A in vitro.

Br J Anaesth. 2024 Jun;132(6):1204-1210. doi: 10.1016/j.bja.2024.02.027. Epub 2024 Apr 8.

[Heparin Resistance After Administration of Andexanet Alfa:Report of a Case].

Kyobu Geka. 2024 Jun;77(6):454-456.

Cardiopulmonary Bypass Circuit Obstruction and Urgent Replacement After the Administration of Andexanet Alfa.

J Cardiothorac Vasc Anesth. 2024 Mar;38(3):780-783. doi: 10.1053/j.jvca.2023.12.001. Epub 2023 Dec 6.

Andexanet Alfa-Induced Heparin Resistance: Sustained Anticoagulant Inefficacy Despite Antithrombin Therapy.

J Cardiothorac Vasc Anesth. 2024 Aug;38(8):1727-1729. doi: 10.1053/j.jvca.2024.03.037. Epub 2024 Mar 27.

Andexanet alpha-induced heparin resistance treated by nafamostat mesylate in a patient undergoing total aortic arch repair for Stanford type A acute aortic dissection: a case report.

JA Clin Rep. 2024 Jan 29;10(1):6. doi: 10.1186/s40981-024-00690-8.

Andexanet Alfa-Induced Heparin Resistance: When Anticoagulation Really Remains Reversed.

J Cardiothorac Vasc Anesth. 2021 Mar;35(3):908-909. doi: 10.1053/j.jvca.2020.11.052. Epub 2020 Nov 28.

Andexanet Alfa for Urgent Reversal of Apixaban Before Aortic Surgery Requiring Cardiopulmonary Bypass: A Case Report.

A A Pract. 2019 Oct 1;13(7):271-273. doi: 10.1213/XAA.0000000000001052.

Successful Nafamostat Mesilate Administration for Andexanet Alfa-Induced Heparin Resistance.

Cureus. 2023 Aug 23;15(8):e44003. doi: 10.7759/cureus.44003. eCollection 2023 Aug.

Andexanet-Alfa-Associated Heparin Resistance in the Context of Hemorrhagic Stroke.

Neurocrit Care. 2022 Oct;37(2):372-376. doi: 10.1007/s12028-022-01573-5. Epub 2022 Aug 5.

引用本文的文献

Andexanet Alfa in Urgent Cardiac Surgery: A Case Report of Edoxaban Reversal for Acute Hemopericardium.

Am J Case Rep. 2025 Mar 30;26:e945265. doi: 10.12659/AJCR.945265.

Direct-acting oral anticoagulant removal by intraoperative hemoadsorption in CABG and/or single valve surgery: interim analysis of the International Safe and Timely Antithrombotic Removal (STAR) registry.

J Cardiothorac Surg. 2025 Jan 20;20(1):74. doi: 10.1186/s13019-024-03326-1.

Andexanet Alfa-Associated Heparin Resistance in Cardiac Surgery: Mechanism and In Vitro Perspectives.

Arterioscler Thromb Vasc Biol. 2025 Jan;45(1):144-156. doi: 10.1161/ATVBAHA.124.321650. Epub 2024 Nov 21.

Andexanet Alfa for Edoxaban Reversal and Associated Thromboelastography Changes in Surgical Pulmonary Embolectomy.

Cureus. 2024 Jun 14;16(6):e62370. doi: 10.7759/cureus.62370. eCollection 2024 Jun.

Andexanet alpha-induced heparin resistance treated by nafamostat mesylate in a patient undergoing total aortic arch repair for Stanford type A acute aortic dissection: a case report.

JA Clin Rep. 2024 Jan 29;10(1):6. doi: 10.1186/s40981-024-00690-8.

A Case of Andexanet Alfa Induced Heparin Resistance in Emergent Aortic Surgery: Successful Anticoagulation Management Using Antithrombin Administration.

Cureus. 2023 Dec 20;15(12):e50856. doi: 10.7759/cureus.50856. eCollection 2023 Dec.

Intraoperative Heparin Resistance after Administration of Andexanet Alfa to Manage an Internal Iliac Artery Aneurysm Rupture: A Case Report.

Ann Vasc Dis. 2023;16(4):273-276. doi: 10.3400/avd.avd.cr.23-00060. Epub 2023 Oct 11.

Perioperative hemostatic management of patients with type A aortic dissection.

Front Cardiovasc Med. 2023 Nov 20;10:1294505. doi: 10.3389/fcvm.2023.1294505. eCollection 2023.

Optimal management of cardiac surgery patients using direct oral anticoagulants: recommendations for clinical practice.

Eur J Cardiothorac Surg. 2023 Oct 4;64(4). doi: 10.1093/ejcts/ezad340.

Successful Nafamostat Mesilate Administration for Andexanet Alfa-Induced Heparin Resistance.

Cureus. 2023 Aug 23;15(8):e44003. doi: 10.7759/cureus.44003. eCollection 2023 Aug.

文献AI研究员

20分钟写一篇综述，助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型，支持多种主流文档格式。

立即体验

Successful Antithrombin Administration in Andexanet Alfa-Associated Heparin Resistance.

作者信息

机构信息

出版信息

相似文献

引用本文的文献

文献AI研究员

用中文搜PubMed

文档翻译

Suppr 超能文献

Successful Antithrombin Administration in Andexanet Alfa-Associated Heparin Resistance.

作者信息

机构信息

出版信息

相似文献

引用本文的文献